|
BHC | Bausch Health Companies Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.21 |
| Leverage | 98.57% |
| Market Cap | $ 1.8B |
| PE | 11.35 |
| Dividend Yield | 0.00% |
| Profit | $ 160.4m |
| Margin | 1.57% |
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.